Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/07/2003WO2003063904A2 Tissue adhesion formation control
08/07/2003WO2003063903A2 Modulation of t lymphocytes using dp iv inhibitors
08/07/2003WO2003063900A1 Process for the preparation of a nutrient formulation
08/07/2003WO2003063885A1 A composition
08/07/2003WO2003063884A1 A herbal pharmaceutical composition for treating siriasis and its process
08/07/2003WO2003063882A1 Cycloglycans suitable to inhibit mammalian infection
08/07/2003WO2003063881A1 Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis
08/07/2003WO2003063880A1 Disruption of islet amyloid by polycyclic compounds
08/07/2003WO2003063879A1 Remedies for glaucoma comprising bunazosin and prostaglandins
08/07/2003WO2003063878A1 Use of polyunsaturated ketones for the treatment of psoriasis
08/07/2003WO2003063877A1 Cefquinome composition for intra-mammary administration in cattle
08/07/2003WO2003063876A2 Methods of treating patients suffering from movement disorders
08/07/2003WO2003063875A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063873A1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-d)-pyrimidine for treating of urinary incontinence
08/07/2003WO2003063872A1 Non-sedating barbituric acid derivatives
08/07/2003WO2003063871A1 Phenylpyrimidine amines as ige inhibitors
08/07/2003WO2003063870A1 A combination treatment for acute myocardial infarction
08/07/2003WO2003063869A1 Anti-viral compounds
08/07/2003WO2003063868A1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
08/07/2003WO2003063867A1 Stable saccharide-free tablets comprising a salt of quinapril or moexipril
08/07/2003WO2003063866A1 Agents which interact with a serotonin transporter for the treatment of cancer
08/07/2003WO2003063865A1 Method of correcting herg channel dysfunction
08/07/2003WO2003063864A2 Heterocyclic compounds which are active as inhibitors of beta lactamases
08/07/2003WO2003063863A1 Antibacterial pharmaceutical composition
08/07/2003WO2003063862A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003WO2003063861A1 Fibrosis inhibitor
08/07/2003WO2003063860A1 Compositions for preventing human cancer and method of preventing human cancer
08/07/2003WO2003063859A1 Suppression of cartilage degradation via the estrogen receptor
08/07/2003WO2003063858A2 Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
08/07/2003WO2003063857A1 A novel dosage form of l-methionine s-sulfoximine
08/07/2003WO2003063856A1 Jelly preparation containing branched amino acids
08/07/2003WO2003063855A1 Chewable tablet containing branched amino acids
08/07/2003WO2003063854A1 Chewable tablet containing branched amino acids
08/07/2003WO2003063853A1 Compositions for lessening mesenteric fat
08/07/2003WO2003063852A1 Therapeutic agent for urinary incontinence
08/07/2003WO2003063851A1 Composition for pharmaceutical or dietetic use for combating hair loss
08/07/2003WO2003063850A1 Medicinal compositions containing vitamin k’s as nerve growth factor potentiator and utilization thereof
08/07/2003WO2003063849A1 Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome
08/07/2003WO2003063848A1 Lutein/zeaxanthin for glare protection
08/07/2003WO2003063847A1 Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
08/07/2003WO2003063846A2 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
08/07/2003WO2003063845A1 Alpha 2 delta ligands to treat tinnitus
08/07/2003WO2003063844A2 Treatment of rheumatoid arthritis using imatinie
08/07/2003WO2003063843A1 Composition for inhalation
08/07/2003WO2003063842A1 Composition for inhalation
08/07/2003WO2003063840A2 Transmucosal delivery of proton pump inhibitors
08/07/2003WO2003063838A1 Dry granulated formulations of azithromycin
08/07/2003WO2003063837A1 Increased-dosage nelfinavir tablet and method of making same
08/07/2003WO2003063834A1 Multi-stage oral drug controlled-release system
08/07/2003WO2003063832A1 Pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors
08/07/2003WO2003063831A2 Immediate release dosage forms containing solid drug dispersions
08/07/2003WO2003063828A1 Jojoba product for reducing weight, blood lipid levels and for the prevention and treatment of cancer
08/07/2003WO2003063826A2 Ophthalmic compositions including oil-in-water emulsions, and methods for making and using the same
08/07/2003WO2003063824A2 Pharmaceutical composition
08/07/2003WO2003063822A2 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
08/07/2003WO2003063821A2 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
08/07/2003WO2003063805A2 Cosmetic or dermatological use of vitamin a or the esters thereof in combination with a partly methylated beta-cyclodextrin
08/07/2003WO2003063800A2 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/07/2003WO2003063796A2 Heterocyclic arylsulfonamidobenzylic compounds
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003063793A2 Fatty acid-containing compositions and methods for the treatment of cytokine mediated disorders
08/07/2003WO2003063789A2 L-carnitine for treatment of hearing loss
08/07/2003WO2003063788A2 PTPase INHIBITORS AND METHODS OF USING THE SAME
08/07/2003WO2003063783A2 Multiple virus replicon culture systems
08/07/2003WO2003063782A2 Kappa-pviia-related conotoxins as organ protectants
08/07/2003WO2003063781A2 Substituted imidazoles as cannabinoid receptor modulators
08/07/2003WO2003063779A2 Selective analgesic agents
08/07/2003WO2003063776A2 Methods and compositions for treating male erectile dysfunction
08/07/2003WO2003063771A2 N4-acylcytosine nucleosides for treatment of viral iinfections
08/07/2003WO2003063764A2 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
08/07/2003WO2003063758A2 Bicyclic cb2 cannabinoid receptor ligands
08/07/2003WO2003063757A2 Auger effect-based cancer therapy method
08/07/2003WO2003063681A2 Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as aids
08/07/2003WO2003063610A1 Oil including omega-3 fatty acids with therapeutic properties
08/07/2003WO2003063593A1 Methods for treating cancer by administering tumor-targetted bacteria and an immunomodulatory agent
08/07/2003WO2003063576A2 Arylsulfonamidobenzylic compounds
08/07/2003WO2003063573A2 Method for treating diseases with omega interferon
08/07/2003WO2003051362A3 Polymorphs of clopidogrel hydrogensulfate
08/07/2003WO2003048375B1 Hybrid glycosylated products and their production and use
08/07/2003WO2003045908A3 Method for controlling angiogenesis in animals
08/07/2003WO2003035002B1 Management of postoperative pain
08/07/2003WO2003032728A8 Methods for preventing or reversing asthma and compositions useful therefor
08/07/2003WO2003030886A3 Allylamides useful in the treatment of alzheimer's disease
08/07/2003WO2003030826A3 Antisense modulation of insulin-like growth factor binding protein 5 expression
08/07/2003WO2003030616A3 21132, a human g-protein coupled receptor family member and uses therefor
08/07/2003WO2003024473A3 Retinoid receptor pan-antagonists for stimulating chondrogenesis
08/07/2003WO2003020911A9 Human schizophrenia gene
08/07/2003WO2003018788B1 Improved nitroreductase enzymes
08/07/2003WO2003015782A3 Receptor-adapted nicotine withdrawal by anti-cholinergic and anti-noradrenergic blockage
08/07/2003WO2003014165A8 EXTRACTION OF β-GLUCAN FROM CEREALS
08/07/2003WO2003009835A3 Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
08/07/2003WO2003008640A3 Asthma-associated gene
08/07/2003WO2003004034B1 Method for inducing analgesia comprising administration alternatively of an opioid receptor agonist and an opioid receptor like receptor 1 agonist for and an implantable infusion pump
08/07/2003WO2002100415A3 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
08/07/2003WO2002096870A3 Sponge-derived terpenoids and methods of use
08/07/2003WO2002066642A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003WO2002064157A3 Localized myocardial injection method for treating ischemic myocardium
08/07/2003WO2002058736A3 Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis
08/07/2003WO2002056873A3 2-substituted dibenzo[a,e]1,2,3-triazolo[4,5-c][7]annulen-8-ones as growth hormone secretagogues
1 ... 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 5398 5399 5400 5401 ... 7860